(Q37315752)

19 August 2017

1 reference

title

Rational design of novel antibacterial vaccines with an emphasis on tuberculosis (English)

1 reference

19 August 2017

0 references

1 reference

Stefan H E Kaufmann

1

0 references

publication date

1 January 2008

1 reference

Scandinavian Journal of Infectious Diseases

19 August 2017

published in

1 reference

19 August 2017

volume

40

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

595-600

1 reference

The contribution of immunology to the rational design of novel antibacterial vaccines

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Pneumococcal vaccines: do they prevent infection and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

A review of vaccine research and development: meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Group B Streptococcus: global incidence and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Identification of a universal Group B streptococcus vaccine by multiple genome screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Envisioning future strategies for vaccination against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Translating innate immunity into immunological memory: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Natural regulatory T cells in infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Maintenance of serum antibody levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540802032759

10.1080/00365540802032759

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference